200 related articles for article (PubMed ID: 30279255)
41. Bing-Neel Syndrome: Update on the Diagnosis and Treatment.
Nanah A; Al Hadidi S
Clin Lymphoma Myeloma Leuk; 2022 Mar; 22(3):e213-e219. PubMed ID: 34674984
[TBL] [Abstract][Full Text] [Related]
42. Bing-Neel syndrome: a case report and systematic review of clinical manifestations, diagnosis, and treatment options.
Grewal JS; Brar PK; Sahijdak WM; Tworek JA; Chottiner EG
Clin Lymphoma Myeloma; 2009 Dec; 9(6):462-6. PubMed ID: 19951888
[TBL] [Abstract][Full Text] [Related]
43. An Autopsy Case of Bing-Neel Syndrome: Discrepancy between the Radiological and Pathological Findings.
Matsuda S; Sekiguchi N; Ito K; Takaoka K; Furuki M; Hirano K; Obayashi M
Intern Med; 2019 Jul; 58(13):1947-1951. PubMed ID: 30918173
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of ibrutinib in a patient with transformed lymphoplasmacytic lymphoma and central nervous system involvement.
Hiemcke-Jiwa LS; Leguit RJ; Radersma-van Loon JH; Westerweel PE; Rood JJM; Doorduijn JK; Huibers MMH; Minnema MC
Leuk Lymphoma; 2018 May; 59(5):1256-1259. PubMed ID: 28849690
[No Abstract] [Full Text] [Related]
45. Dose of ibrutinib in Waldenström macroglobulinaemia: Less can be more.
Tohidi-Esfahani I; Trotman J
Br J Haematol; 2023 Jun; 201(5):807-808. PubMed ID: 36715656
[TBL] [Abstract][Full Text] [Related]
46. Ibrutinib discontinuation in Waldenström macroglobulinemia: Etiologies, outcomes, and IgM rebound.
Gustine JN; Meid K; Dubeau T; Severns P; Hunter ZR; Guang Y; Xu L; Treon SP; Castillo JJ
Am J Hematol; 2018 Aug; 93(4):511-517. PubMed ID: 29280186
[TBL] [Abstract][Full Text] [Related]
47. Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study.
Younes A; Thieblemont C; Morschhauser F; Flinn I; Friedberg JW; Amorim S; Hivert B; Westin J; Vermeulen J; Bandyopadhyay N; de Vries R; Balasubramanian S; Hellemans P; Smit JW; Fourneau N; Oki Y
Lancet Oncol; 2014 Aug; 15(9):1019-26. PubMed ID: 25042202
[TBL] [Abstract][Full Text] [Related]
48. Bing-Neel syndrome - Bilateral cavernous sinus lymphoma causing visual failure.
Pham C; Griffiths JD; Kam A; Hunn MK
J Clin Neurosci; 2017 Nov; 45():134-135. PubMed ID: 28765059
[TBL] [Abstract][Full Text] [Related]
49. Treatment of Bing-Neel syndrome with first line sequential chemoimmunotherapy: A case report.
Gavriatopoulou M; Ntanasis-Stathopoulos I; Moulopoulos LA; Manaios A; Fotiou D; Eleutherakis-Papaiakovou E; Migkou M; Bourgioti C; Terpos E; Kastritis E; Dimopoulos MA
Medicine (Baltimore); 2019 Nov; 98(44):e17794. PubMed ID: 31689856
[TBL] [Abstract][Full Text] [Related]
50. Preclinical models of Waldenström's macroglobulinemia and drug resistance.
Ailawadhi S; Paulus A; Chanan-Khan A
Best Pract Res Clin Haematol; 2016 Jun; 29(2):169-178. PubMed ID: 27825463
[TBL] [Abstract][Full Text] [Related]
51. Mixed Diffuse and Tumoral Form of Bing-Neel Syndrome Successfully Treated with Ibrutinib.
Naveed Ahmad JA; Schroeder BA; Yun JPT; Aboulafia DM
Case Rep Oncol; 2023; 16(1):1353-1361. PubMed ID: 37946745
[TBL] [Abstract][Full Text] [Related]
52. MYD88 Mutations and Response to Ibrutinib in Waldenström's Macroglobulinemia.
Treon SP; Xu L; Hunter Z
N Engl J Med; 2015 Aug; 373(6):584-6. PubMed ID: 26244327
[No Abstract] [Full Text] [Related]
53. Development of the Bruton's tyrosine kinase inhibitor ibrutinib for B cell malignancies.
Gayko U; Fung M; Clow F; Sun S; Faust E; Price S; James D; Doyle M; Bari S; Zhuang SH
Ann N Y Acad Sci; 2015 Nov; 1358():82-94. PubMed ID: 26348626
[TBL] [Abstract][Full Text] [Related]
54. [Bing-Neel syndrome revealing Waldenström's macroglobulinemia].
Drouet T; Behin A; Psimaras D; Choquet S; Guillevin R; Hoang Xuan K
Rev Neurol (Paris); 2010 Jan; 166(1):66-75. PubMed ID: 19403149
[TBL] [Abstract][Full Text] [Related]
55. Ibrutinib Monotherapy in Symptomatic, Treatment-Naïve Patients With Waldenström Macroglobulinemia.
Treon SP; Gustine J; Meid K; Yang G; Xu L; Liu X; Demos M; Kofides A; Tsakmaklis N; Chen JG; Munshi M; Chan G; Dubeau T; Raje N; Yee A; O'Donnell E; Hunter ZR; Castillo JJ
J Clin Oncol; 2018 Sep; 36(27):2755-2761. PubMed ID: 30044692
[TBL] [Abstract][Full Text] [Related]
56. Ibrutinib therapy for lymphoplasmacytic lymphoma.
Helber MJ; Moore JE; Williams AM; Meacham PJ; Rothberg PG; Zent CS
Am J Hematol; 2017 Sep; 92(9):E542-E544. PubMed ID: 28543765
[No Abstract] [Full Text] [Related]
57. Targets for Ibrutinib Beyond B Cell Malignancies.
Berglöf A; Hamasy A; Meinke S; Palma M; Krstic A; Månsson R; Kimby E; Österborg A; Smith CI
Scand J Immunol; 2015 Sep; 82(3):208-17. PubMed ID: 26111359
[TBL] [Abstract][Full Text] [Related]
58. Novel diagnostic approaches in Bing-Neel syndrome.
Ly KI; Fintelmann F; Forghani R; Schaefer PW; Hochberg EP; Hochberg FH
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):180-3. PubMed ID: 21856555
[TBL] [Abstract][Full Text] [Related]
59. Waldenström Macroglobulinemia-Associated Peripheral Neuropathy in the Brachial Plexus With Bing-Neel Syndrome Diagnosed Through Repeated Cerebrospinal Tests.
Hatasa M; Imoto N; Komori S; Nosaki Y; Kurahashi S
Cureus; 2024 Jan; 16(1):e52400. PubMed ID: 38361676
[TBL] [Abstract][Full Text] [Related]
60. B type-Bing-Neel syndrome with MRI follow-up: a case report and review of its presentations.
Crombe A; Alberti N; Menegon P; Desblache J; Frulio N; Tourdias T
J Neuroradiol; 2014 Dec; 41(5):362-5. PubMed ID: 24994685
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
